NRAS and central nervous system cancer: In a glioma study, they report on the oncogenic role of maternally expressed 3 (MEG3) as a tumor suppressor lncRNA that is downregulated in gliomas [34] and nuclear paraspeckle assembly transcript 1 (NEAT1) on by competing for miR-let-7e and modulating the expression of signal transducer and activator of transcription 3 (STAT3) and NRAS proto-oncogene, GTPase (NRAS) [34,35].